Ujvira Trastuzumab Emtansine 100 mg Injection
Ujvira Trastuzumab Emtansine 100 mg Injection is an advanced targeted therapy used for treating HER2-positive breast cancer. It combines the monoclonal antibody trastuzumab with the cytotoxic agent emtansine, delivering precise cancer-fighting action directly to cancer cells while minimizing systemic toxicity. This therapy is designed for patients who have previously received trastuzumab and chemotherapy and require a potent next-line treatment option.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
Composition and Content
- Active Ingredient: Trastuzumab emtansine 100 mg
- Formulation: Sterile powder for injection
- Mechanism: Antibody-drug conjugate targeting HER2-positive cancer cells
- Excipients: May include sugars, buffers, and stabilizers (specific formulation details provided by manufacturer)
How to Use & Doses
- Administration: Intravenous infusion over 30–90 minutes under medical supervision
- Dosage: Typically 3.6 mg/kg body weight every 3 weeks (as per oncologist prescription)
- Monitoring: Regular cardiac function tests and liver function assessments are recommended during treatment
⚠️ Always use under strict medical supervision. Dosing may vary based on patient condition and prior therapies.
Uses and Treatments
Ujvira Trastuzumab Emtansine is used for:
- HER2-positive metastatic breast cancer
- Patients who progressed after trastuzumab and chemotherapy
- Targeted therapy to minimize damage to normal cells
This therapy is often part of an advanced cancer management plan and may be combined with supportive care for better outcomes.
Advantages
- Highly targeted, reducing systemic toxicity compared to conventional chemotherapy
- Convenient dosing schedule (every 3 weeks)
- Proven efficacy in prolonging progression-free survival in HER2-positive patients
- Can be administered in outpatient settings under monitoring
Storage Conditions
- Store in a refrigerator at 2–8°C
- Protect from light and freezing
- Reconstituted solution should be used immediately or stored as per manufacturer instructions
Alternative Indian Brands
Several Indian pharmaceutical companies manufacture trastuzumab-based therapies and antibody-drug conjugates that may serve as alternatives:
- Kanjinti – Trastuzumab biosimilar
- Ogivri – Trastuzumab biosimilar
- Trazimera – Trastuzumab biosimilar
- Trastuzumab Emtansine biosimilars (availability may vary)
Purchase Today Online Ujvira Trastuzumab Emtansine 100 mg Injection – GlobMedIndia
Buy Ujvira Trastuzumab Emtansine 100 mg Injection online at GlobMedIndia. Fast, safe delivery of Anti-Cancer Medicines to India – Nagpur, Mumbai, Delhi, Pune, Gujarat, Kerala, Rajasthan, and Surat.
- Buy Ujvira Trastuzumab Emtansine 100 mg online India
- Ujvira Trastuzumab Emtansine 100 mg Injection for breast cancer
- Anti-cancer medicines online delivery India
- HER2-positive breast cancer treatment Nagpur Mumbai Delhi
- GlobMedIndia cancer medicines safe shipping
- Trastuzumab emtansine injection alternatives India
“Purchase Ujvira Trastuzumab Emtansine 100 mg Injection online today from GlobMedIndia – The trusted medicine exporter.
Get fast and safe delivery of high-quality anti-cancer medicines across India, including Nagpur, Mumbai, Delhi, Pune, Gujarat, Kerala, Rajasthan, and Surat. Ujvira offers targeted HER2-positive breast cancer treatment with maximum efficacy and minimal side effects. Contact us via WhatsApp, Phone, or Email to place your order today!”
